TSA PreCheck will remain operational for now, a spokesperson for the agency said Sunday, reversing earlier indications that the Department of Homeland Security’s expedited screening program would be ...

Amyloid-targeted monoclonal antibodies are the first disease-modifying therapies (DMTs) approved for Alzhemier’s disease (AD). Aducanumab received accelerated approval by the FDA but was not fully ...

Section 1. Background. In Executive Order 14257 of April 2, 2025 (Regulating Imports With a Reciprocal Tariff To Rectify Trade Practices That Contribute to Large and Persistent Annual United States ...

The push to expand pre-kindergarten programs is on. Last school year, public pre-K programs received their biggest-ever boost in state funding. Enrollment in state pre-K programs nationwide increased ...

The US Air Force has begun modifying a Boeing 747 that was donated to the US by Qatar over the summer, an Air Force spokesperson said on Monday. The plane will be used for “executive airlift support,” ...

One of my aggravating moments is when I read in a newspaper, or hear on a television newscast, the total misuse of the words “democracy” (noun), democratic (adjective), and Democrat (proper noun). How ...

Section 1. Background. In Executive Order 14257 of April 2, 2025 (Regulating Imports With a Reciprocal Tariff To Rectify Trade Practices That Contribute to Large and Persistent Annual United States ...

Bhaskar Ahuja, CEO of investment firm Sand Hill Road Technologies Fund, is a venture growth strategist helping startups and investors scale. Not too long ago, access to high-growth private companies ...

The beef had been aged dry for 30 days, and it changed my life. Not the way you’re thinking. I didn’t eat the life-changing meat. I just read about it in an article I was editing — and my relationship ...

Significant unmet needs in SMA management include therapy access, fatigue, reproductive health, and emerging phenotypes in older patients. Intrathecal gene therapy offers potential for older SMA ...

Please provide your email address to receive an email when new articles are posted on . Researchers observed what they called “alarming” underutilization of disease-modifying therapies for sickle cell ...

Annalisa Morgan, MD, looks forward to discussing the upcoming 2025 ACTRIMS Forum, focusing on disease-modifying therapy use for patients with an inflammatory relapsing-remitting phenotype of multiple ...